Category : Search result: shareholder dividends


Pfizer spent 18% on R&D, 27% to shareholders in 2024

Analysis reveals US pharma giant Pfizer allocated more revenue to shareholders than R&D in 2024, as Trump's drug price rhetoric targets allies over corporate profits. Explore the real drivers of high US medicine costs.

BP names Meg O'Neill as new chief executive

BP has announced Meg O'Neill will become its new CEO on 1 April, replacing Murray Auchincloss. The oil giant's chair calls for 'increased rigour' to boost shareholder value. Read the full story.

Monzo Shareholders Plot Coup to Oust Chair Hoffman

A major shareholder revolt rocks Monzo as investors holding over 40% of stock seek to oust chair Gary Hoffman and reinstate CEO TS Anil. Discover the internal conflict threatening the fintech's IPO plans.

Amigo Loans pivots from lending to gold mining

Amigo Loans shareholders could see golden returns as the company transforms from failed lender to mining venture under Australian leadership. Discover the dramatic turnaround story.

Tesla Backs Musk's $56bn Deal - Trillionaire Path Clear

Tesla shareholders have overwhelmingly approved Elon Musk's unprecedented $56 billion compensation package, potentially catapulting the CEO into becoming the world's first trillionaire. Discover how this landmark decision reshapes corporate governance and

Norway fund rejects Musk's £44bn Tesla pay deal

In a stunning shareholder revolt, Norway's massive sovereign wealth fund has voted against Elon Musk's controversial compensation package at Tesla's annual meeting, dealing a major setback to the billionaire CEO.

Why Australia's CEOs Rarely Lose Their Bonuses

New research exposes the corporate bonus culture where executives rarely face financial consequences for poor performance. Discover what it truly takes for Australia's highest-paid bosses to miss out on their lucrative incentives.

Page 1 of 1